tiprankstipranks
Trending News
More News >
Epigenomics AG (GB:0QXH)
:0QXH

Epigenomics (0QXH) Price & Analysis

Compare
0 Followers

0QXH Stock Chart & Stats


Financials

0QXH FAQ

What was Epigenomics AG’s price range in the past 12 months?
Epigenomics AG lowest share price was €0.89 and its highest was €3.80 in the past 12 months.
    What is Epigenomics AG’s market cap?
    Epigenomics AG’s market cap is €771.72K.
      When is Epigenomics AG’s upcoming earnings report date?
      Epigenomics AG’s upcoming earnings report date is Aug 06, 2025 which is in 53 days.
        How were Epigenomics AG’s earnings last quarter?
        Epigenomics AG released its earnings results on May 07, 2025. The company reported -€2.915 earnings per share for the quarter, missing the consensus estimate of N/A by -€2.915.
          Is Epigenomics AG overvalued?
          According to Wall Street analysts Epigenomics AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Epigenomics AG pay dividends?
            Epigenomics AG does not currently pay dividends.
            What is Epigenomics AG’s EPS estimate?
            Epigenomics AG’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Epigenomics AG have?
            Epigenomics AG has 876,949 shares outstanding.
              What happened to Epigenomics AG’s price movement after its last earnings report?
              Epigenomics AG reported an EPS of -€2.915 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Epigenomics AG?
                Currently, no hedge funds are holding shares in GB:0QXH

                Company Description

                Epigenomics AG

                Epigenomics AG is a molecular diagnostics company, focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, North America, Asia, and the Rest of the world.
                Similar Stocks
                Company
                Price & Change
                Follow
                B.R.A.I.N. Biotechnology Research and Information Network
                Heidelberg Pharma AG
                Bio-Gate AG
                Vitruvia Medical AG
                SYNLAB AG
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis